193 related articles for article (PubMed ID: 35983994)
21. Multiple Histone Lysine Methyltransferases Are Required for the Establishment and Maintenance of HIV-1 Latency.
Nguyen K; Das B; Dobrowolski C; Karn J
mBio; 2017 Feb; 8(1):. PubMed ID: 28246360
[TBL] [Abstract][Full Text] [Related]
22. Alveolar Differentiation Drives Resistance to KRAS Inhibition in Lung Adenocarcinoma.
Li Z; Zhuang X; Pan CH; Yan Y; Thummalapalli R; Hallin J; Torborg S; Singhal A; Chang JC; Manchado E; Dow LE; Yaeger R; Christensen JG; Lowe SW; Rudin CM; Joost S; Tammela T
Cancer Discov; 2024 Feb; 14(2):308-325. PubMed ID: 37931288
[TBL] [Abstract][Full Text] [Related]
23. Inhibitor of Differentiation-1 Sustains Mutant
Román M; López I; Guruceaga E; Baraibar I; Ecay M; Collantes M; Nadal E; Vallejo A; Cadenas S; Miguel ME; Jang JH; Martin-Uriz PS; Castro-Labrador L; Vilas-Zornoza A; Lara-Astiaso D; Ponz-Sarvise M; Rolfo C; Santos ES; Raez LE; Taverna S; Behrens C; Weder W; Wistuba II; Vicent S; Gil-Bazo I
Cancer Res; 2019 Feb; 79(3):625-638. PubMed ID: 30563891
[TBL] [Abstract][Full Text] [Related]
24. The lysine methyltransferase Ehmt2/G9a is dispensable for skeletal muscle development and regeneration.
Zhang RH; Judson RN; Liu DY; Kast J; Rossi FM
Skelet Muscle; 2016; 6():22. PubMed ID: 27239264
[TBL] [Abstract][Full Text] [Related]
25. EHMT2/G9a Inhibits Aortic Smooth Muscle Cell Death by Suppressing Autophagy Activation.
Chen TQ; Hu N; Huo B; Masau JF; Yi X; Zhong XX; Chen YJ; Guo X; Zhu XH; Wei X; Jiang DS
Int J Biol Sci; 2020; 16(7):1252-1263. PubMed ID: 32174799
[TBL] [Abstract][Full Text] [Related]
26. Tumor progression and chromatin landscape of lung cancer are regulated by the lineage factor GATA6.
Arnal-Estapé A; Cai WL; Albert AE; Zhao M; Stevens LE; López-Giráldez F; Patel KD; Tyagi S; Schmitt EM; Westbrook TF; Nguyen DX
Oncogene; 2020 Apr; 39(18):3726-3737. PubMed ID: 32157212
[TBL] [Abstract][Full Text] [Related]
27. Enhanced expression of EHMT2 is involved in the proliferation of cancer cells through negative regulation of SIAH1.
Cho HS; Kelly JD; Hayami S; Toyokawa G; Takawa M; Yoshimatsu M; Tsunoda T; Field HI; Neal DE; Ponder BA; Nakamura Y; Hamamoto R
Neoplasia; 2011 Aug; 13(8):676-84. PubMed ID: 21847359
[TBL] [Abstract][Full Text] [Related]
28. Identification of tumorigenic cells in Kras(G12D)-induced lung adenocarcinoma.
Cho HC; Lai CY; Shao LE; Yu J
Cancer Res; 2011 Dec; 71(23):7250-8. PubMed ID: 22088965
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of EHMT2 Induces a Robust Antiviral Response Against Foot-and-Mouth Disease and Vesicular Stomatitis Virus Infections in Bovine Cells.
Singh N; Ramĩrez-Carvajal L; de Los Santos T; Golding MC; Long CR
J Interferon Cytokine Res; 2016 Jan; 36(1):37-47. PubMed ID: 26418342
[TBL] [Abstract][Full Text] [Related]
30. BIX-01294 induces autophagy-associated cell death via EHMT2/G9a dysfunction and intracellular reactive oxygen species production.
Kim Y; Kim YS; Kim DE; Lee JS; Song JH; Kim HG; Cho DH; Jeong SY; Jin DH; Jang SJ; Seol HS; Suh YA; Lee SJ; Kim CS; Koh JY; Hwang JJ
Autophagy; 2013 Dec; 9(12):2126-39. PubMed ID: 24322755
[TBL] [Abstract][Full Text] [Related]
31. Cinobufagin induces FOXO1-regulated apoptosis, proliferation, migration, and invasion by inhibiting G9a in non-small-cell lung cancer A549 cells.
Zhang L; Liang B; Xu H; Gong Y; Hu W; Jin Z; Wu X; Chen X; Li M; Shi L; Shi Y; Wang Y; Yang L
J Ethnopharmacol; 2022 Jun; 291():115095. PubMed ID: 35176466
[TBL] [Abstract][Full Text] [Related]
32. Foxm1 transcription factor is required for the initiation of lung tumorigenesis by oncogenic Kras(G12D.).
Wang IC; Ustiyan V; Zhang Y; Cai Y; Kalin TV; Kalinichenko VV
Oncogene; 2014 Nov; 33(46):5391-6. PubMed ID: 24213573
[TBL] [Abstract][Full Text] [Related]
33. SETDB1 Inhibits p53-Mediated Apoptosis and Is Required for Formation of Pancreatic Ductal Adenocarcinomas in Mice.
Ogawa S; Fukuda A; Matsumoto Y; Hanyu Y; Sono M; Fukunaga Y; Masuda T; Araki O; Nagao M; Yoshikawa T; Goto N; Hiramatsu Y; Tsuda M; Maruno T; Nakanishi Y; Hussein MS; Tsuruyama T; Takaori K; Uemoto S; Seno H
Gastroenterology; 2020 Aug; 159(2):682-696.e13. PubMed ID: 32360551
[TBL] [Abstract][Full Text] [Related]
34. Protein-lysine methyltransferases G9a and GLP1 promote responses to DNA damage.
Ginjala V; Rodriguez-Colon L; Ganguly B; Gangidi P; Gallina P; Al-Hraishawi H; Kulkarni A; Tang J; Gheeya J; Simhadri S; Yao M; Xia B; Ganesan S
Sci Rep; 2017 Nov; 7(1):16613. PubMed ID: 29192276
[TBL] [Abstract][Full Text] [Related]
35. MDC1 methylation mediated by lysine methyltransferases EHMT1 and EHMT2 regulates active ATM accumulation flanking DNA damage sites.
Watanabe S; Iimori M; Chan DV; Hara E; Kitao H; Maehara Y
Sci Rep; 2018 Jul; 8(1):10888. PubMed ID: 30022091
[TBL] [Abstract][Full Text] [Related]
36. H3K9 histone methyltransferase G9a promotes lung cancer invasion and metastasis by silencing the cell adhesion molecule Ep-CAM.
Chen MW; Hua KT; Kao HJ; Chi CC; Wei LH; Johansson G; Shiah SG; Chen PS; Jeng YM; Cheng TY; Lai TC; Chang JS; Jan YH; Chien MH; Yang CJ; Huang MS; Hsiao M; Kuo ML
Cancer Res; 2010 Oct; 70(20):7830-40. PubMed ID: 20940408
[TBL] [Abstract][Full Text] [Related]
37. EHMT2 is a metastasis regulator in breast cancer.
Kim K; Son MY; Jung CR; Kim DS; Cho HS
Biochem Biophys Res Commun; 2018 Feb; 496(2):758-762. PubMed ID: 29337058
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic priming by EHMT1/EHMT2 in acute lymphoblastic leukemia induces TP53 and TP73 overexpression and promotes cell death.
Silva-Carvalho AÉ; Alencar APD; Resende MR; da Costa DF; Nonino A; Neves FAR; Saldanha-Araujo F
Toxicol In Vitro; 2020 Dec; 69():104992. PubMed ID: 32889036
[TBL] [Abstract][Full Text] [Related]
39. EHMT2 (G9a) activation in mantle cell lymphoma and its associated DNA methylation and gene expression.
Wang J; Xu H; Ge S; Xue C; Li H; Jing X; Liang K; Zhang X; Zhang C
Cancer Biol Med; 2021 Oct; 19(6):836-49. PubMed ID: 34633777
[TBL] [Abstract][Full Text] [Related]
40. The novel prognostic marker, EHMT2, is involved in cell proliferation via HSPD1 regulation in breast cancer.
Kim SK; Kim K; Ryu JW; Ryu TY; Lim JH; Oh JH; Min JK; Jung CR; Hamamoto R; Son MY; Kim DS; Cho HS
Int J Oncol; 2019 Jan; 54(1):65-76. PubMed ID: 30365075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]